Rapid Development of Antimicrobial Peptides
We are dedicated to the rapid development of antimicrobial peptides (AMPs) as powerful alternatives to conventional small molecule antibiotics. Our focus targets urgent global risks including antimicrobial resistance—one of the greatest threats to modern medicine.